Adjuvant antioxidant therapy in varicocele infertility


Cite item

Full Text

Open Access Open Access
Restricted Access Access granted
Restricted Access Subscription or Fee Access

Abstract

Introduction Infertility affects an estimated 15% of couples globally. Male factor infertility accounts for about a half of infertility cases. About 40% of infertile men have varicocele. The aim of this study was to investigate the efficacy and safety of a complex of acetyl-L-carnitine, L-carnitine fumarate and alpha-lipoic acid (SpermActin-forte) (SA) for adjuvant antioxidant therapy after microsurgical varicocelectomy (MVE) in men with varicocele and assess its impact on the level of DNA fragmentation in sperm cells. Materials and methods This is an open, prospective, randomized trial comprising 114 men aged 25-45 (mean 34.1±12.1) years who underwent MVE. The patients were allocated to receive either adjuvant SA (n=38), SA in combination with a vitamin complex (VC) (n=38) or no adjuvant therapy (n=38). The efficacy was assessed at 3 months by testing standard semen parameters and the level of sperm DNA fragmentation. Results MVE led to a 21.7% increase in the progressive sperm motility compared to the baseline level. In patients receiving SA, this was by 76.7% due to active sperm motility (category A) at 3 months. MVE with concurrent supplementation of SA resulted in a 22.3% decrease in the level of sperm DNA fragmentation at 3 months. When used in the postoperative period after MVE, SA and VC resulted in a 27% increase in the sperm concentration at 3 months. There were no side effects of pharmacotherapy. The statistical significance of the change in variables was calculated using the Wilcoxon test. Critical level а=0.05 was established for all criteria. Conclusion Using nutraceuticals (SA) after MVE is an effective and safe adjuvant antioxidant therapy of male infertility in patients with varicocele which leads to an improvement in the basic sperm parameters (sperm concentration and motility) and a decrease in the level of sperm DNA fragmentation in the short term. Adjuvant antioxidant therapy of varicocele infertility potentiates the effects of monotherapy (both medical and surgical), leads to an increase in its effectiveness and shortens the time to pregnancy. Further studies in this field are needed to assess long-term outcomes of the treatment.

Full Text

Restricted Access

About the authors

S. I Gamidov

I.M. Sechenov First Moscow State Medical University of Minzdrav of Russia; V.I. Kulakov Research Center for Obstetrics, Gynecology and Perinatology of Minzdrav of Russia

Email: s_gamidov@oparina4.ru
Dr.Med.Sci., Prof. at the Department of Obstetrics, Gynecology, Perinatology and Reproductology; Head of the Department of Andrology and Urology

R. I Ovchinnikov

V.I. Kulakov Research Center for Obstetrics, Gynecology and Perinatology of Minzdrav of Russia

Email: r_ovchinnikov@oparina4.ru
Ph.D., Head of the Department of Andrology and Urology, Clinic

A. Yu Popova

V.I. Kulakov RCOGP; V.I. Kulakov Research Center for Obstetrics, Gynecology and Perinatology of Minzdrav of Russia

Email: a_popova@oparina4.ru
Ph.D., Senior Researcher at the Department of Andrology and Urology; Associate Professor at the Department of Obstetrics, Gynecology, Neonatology, Anesthesiology and Reanimatology

A. Yu Avakyan

Outpatient Clinic №180 of the Moscow Health Department

Email: armmed1@mail.ru
Head of the Department of Urology

G. T Sukhikh

I.M. Sechenov First Moscow State Medical University of Minzdrav of Russia; V.I. Kulakov Research Center for Obstetrics, Gynecology and Perinatology of Minzdrav of Russia

Academician of the RAS, Dr.Med.Sci., Professor, Head of the Department of Obstetrics and Gynecology; Director

References

  1. Stone B.A., Alex A., Werlin L.B., Marrs R.P. Age thresholds for changes in semen parameters in men. Fertil Steril. 2013 Oct;100(4):952-8. doi: 10.1016/j.fertnstert.2013.05.046. Epub 2013 Jun 27.
  2. Irvine D.S. Epidemiology and aetiology of male infertility. Hum. Reprod. 1998;13(Suppl. 1):33-44.
  3. Lenzi A., Lombardo F., Sgro P., Salacone P., Caponecchia L., Dondero F., Gandini L. Use of carnitine therapy in selected cases of male factor infertility: a double-blind crossover trial. Fertil Steril 2003;79(2):292-300.
  4. Tremellen K. Oxidative stress and male infertility - a clinical perspective. Hum Reprod Update 2008;14:243-258. Doi: 10.1093/ humupd/dmn004. Epub 2008 Feb 14.
  5. Agarwal A., Makker K., Sharma R. Clinical relevance of oxidative stress in male factor infertility: an update. Am J Reprod Immunol 2008;59:2-11. doi: 10.1111/j.1600-0897.2007.00559.x
  6. Гамидов С.И., Тажетдинов О.Х. Результаты открытого сравнительного исследования препаратов Спеман и СпермАктин в качестве средств лечения идиопатической патозооспермии. Андрология и генитальная хирургия. 2011;2:61-65
  7. Spano M., Bonde J.P., Hjollund H.I. et al. Sperm chromatin damage impairs human fertility. The Danish First Pregnancy Planner Study Team. Fertil. Steril. 2000; 73: 43-50
  8. Попова А.Ю., Гамидов С.И., Овчинников Р.И. Использование антиоксидантов в комбинированной терапии мужского бесплодия при воспалительных заболеваниях. Эффективная фармакотерапия. Урология и Нефрология. 2015; 4(35):34-38

Supplementary files

Supplementary Files
Action
1. JATS XML

This website uses cookies

You consent to our cookies if you continue to use our website.

About Cookies